• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  fully human, antagonistic IgG1 monoclonal antibody targeting IL-27 subunit alpha (p28)
Date Designated:  10/08/2020
Orphan Designation:  Treatment of hepatocellular carcinoma
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Surface Oncology
50 Hampshire Street, 8th Floor
Cambridge, Massachusetts 02139
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.